Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intravenous Dexmedetomidine in FESS
NCT05595083Unknown
- Sponsor
- Kafrelsheikh University
- Start
- Nov 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, triple-blind trial of dexmedetomidine (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Fromme's scores of surgical field quality. Status: unknown.
02
Drugs
dexmedetomidine
Beyond the preview
Go deeper on NCT05595083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05595083.